Clinical Trials

Novartis- Victorian 2-Prevent

• high cholesterol

Amgen 133: Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Participants With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

• Obesity
• Overweight

Cardiovascular Clinical Trial - AMGEN - 890 Olpasiran

Cardiovascular Clinical Trial - Abbott - Jeti Registry

Cardiovascular Clinical Trial - Abiomed - STEMI-DTU

Cardiovascular Clinical Trial - Abiomed, Inc - Abbott ABT-CIP-10416 (Aveir DR)

Cardiovascular Clinical Trial - Ablative Solutions - Ablative Solution - CR0002 The TARGET - Ablative Solutions CR0002 The Target BP I

Cardiovascular Clinical Trial - Tendyne - Summit